Methods: At HCMC Eye hospital, seventy-six patients (76 eyes) with newly diagnosed primary open-angle glaucoma, pseudoexfoliation glaucoma or pigmentary glaucoma were randomized to receive 360° SLT (SLT group) or Tafluprost 0.0015% at night (PGA group).